Resistin: A new marker of cardiorenal risk

American Journal of Hypertension

Volumn 23, Issue 6, 2010, Pages 585-

  Mulè, Giuseppe ^a   Cottone, Santina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RESISTIN;

ATHEROGENESIS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; HEART DISEASE; HUMAN; INFLAMMATION; KIDNEY DISEASE; MICROALBUMINURIA; NOTE; PRIORITY JOURNAL;

ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HUMANS; RESISTIN; RISK;

EID: 77952538365     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.53     Document Type: Note

References (6)

1. Stringer DM, DeClercq VC, Hunt RWT, Baranowsky MS, Taylor CG, Zahradka P. Inflammatory action of adiponectin, leptin and resistin. In Bradford PG (ed). Adipose Tissue and Inflammation. CRC Press: New York, 2009, pp 167-185.
2. Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ, Meigs JB. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 2009; 53:754-762.
3. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17:986-993.
4. Tsioufis C, Dimitriadis K, Selima M, Miliou A, Toutouzas K, Roussos D, Stefanadi E, Tousoulis D, Kallikazaros I, Stefanadis C. Association of resistin with urinary albumin excretion in non-diabetic patients with essential hypertension. Am J Hypertens 2010; 23:681-686.
5. Cottone S, Mulè G, Nardi E, Lorito MC, Guarneri M, Arsena R, Briolotta C, Vadalà A, Cerasola G. Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 2007; 21:167-172.
6. Cottone S, Vadalà A, Mangano MT, Riccobene R, Vella MC, Neri AL, Mulé G, Piazza G, Amato F, Zagarrigo C, Cerasola G. Endothelium-derived factors in microalbuminuric and nonmicroalbuminuric essential hypertensives. Am J Hypertens 2000; 13:172-176.